Search results>Research work

Ongoing Phase 1/2 Study Of Incb050465, A Selective Pi3kδ Inhibitor, For The Treatment Of Patients (Pts) With Relapsed/Refractory (R/R) B‐Cell Malignancies (Citadel‐101)

Authors
Publication date
1 June 2017
Publisher
'Wiley'
Doi

    Abstract

    Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137307/1/hon2438_139.pd

      Similar works

      Full text

      Available Versions

      Deep Blue Documents

      redirect
      oaioai:deepblue.lib.umich.edu:202...
      Last time updated on 18/04/2019

      Crossref

      redirect
      oaiinfo:doi/10.1002%2Fhon.2438_13...
      Last time updated on 04/12/2019